LCK JNK 1 LLC

Holdings History for Scinai Immunotherapeutics Ltd. - American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

Investment type: Equity / American Depositary Shares, each representing 4,000 Ordinary Shares, no par value
Latest Disclosed Shares Owned: 80,757 shares
Security Ownership %: 9.5%

LCK JNK 1 LLC ownership in Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

04 Mar 2025 - LCK JNK 1 LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 80,757 shares of Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value. This represents 9.5% ownership of the company. This is the first filing by LCK JNK 1 LLC disclosing ownership of Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
LCK JNK 1 LLC	9.5%	0%		80,757	0			13G/A	09 Feb 2025	04 Mar 2025, 21:58
LCK JNK 1 LLC	9.5%			80,757				13G	09 Feb 2025	24 Feb 2025, 06:04